Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meitav Issuances is a financial services company based in Israel, serving as the dedicated issuance and underwriting vehicle for Meitav Investment House (formerly Meitav Dash). The company is primarily responsible for managing the issuance of bonds, debt instruments, and structured financial products on the Tel Aviv Stock Exchange (TASE). While it plays a critical role in the Israeli capital markets by providing underwriting and financing services to various sectors, including biotechnology and healthcare, Meitav Issuances is not a life sciences company and does not engage in research, development, or clinical trials. It acts as a financial intermediary and reporting corporation for the broader Meitav group's capital raising activities. The firm is a key facilitator for Israeli biotech companies seeking to access public debt and equity markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meitav Issuances.